US$ 20.28
tirzepatide aetna coverage Does Cover Zepbound? 2026 by Plan Type Sleep apnea and Aetna coverage
Description
STEP-1 showed 39% of semaglutide weight loss was lean mass

The dual incretin advantage Tirzepatide activates two incretin receptors simultaneously: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)

If you are switching medications or managing multiple prescriptions, this visual distinction becomes especially important

It is standard tiered pricing

The SURMOUNT clinical trials demonstrated average weight loss of 1522% of body weight over 72 weeks, with higher percentages observed at the maximum 15 mg dose